MOTS-c, discovered by researchers at the University of Southern California around 2012, improves glucose metabolism in skeletal muscle, suggesting benefits for diabetes, obesity, and aging
Mounjaro and Zepbound contain tirzepatide, which activates both GLP-1 and GIP receptors and has produced some of the strongest average weight loss outcomes in the obesity medicine clinical literature
No serious safety issues arose and the drug progressed to the next stage
Generally, you can expect to see and feel subtle changes within the first 4 to 6 weeks
J Atheroscler Thromb (2019) 26(3):23345
People who also take Metformin alongside Semaglutide should discuss any planned dietary changes with their healthcare provider, as dietary shifts can affect how both medications perform